Busschbach, Jan J.V.; Brouwer, Werner B.F.; van der … - In: PharmacoEconomics 13 (1998) 1 Part 1, pp. 21-34
This article provides an outline for a cost-effectiveness analysis of a drug that slows the consequences of Alzheimer's disease. Such an analysis cannot easily be performed for 2 main reasons. The first is that often relatives and friends, rather than professionals, take care of the patient....